{"id":"W3092236290","doi":"10.1186/s12885-020-07374-3","title":"Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Occupational Cancer Research Centre; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"Canadian Institutes of Health Research; Genome British Columbia; Michael Smith Health Research BC; BC Cancer Foundation; Genome Canada","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Hodgkin's lymphoma; Oncology; Chemotherapy regimen; Cost effectiveness; Cost-effectiveness analysis; Incremental cost-effectiveness ratio; Internal medicine; Cancer; Hodgkin lymphoma; Lymphoma; Chemotherapy; Vincristine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000132694,0.00017015,0.0006751777,0.0001260566,0.00001781379,0.000007823222,0.00007026987,0.00005379085,0.0001797759],"category_scores_gemma":[0.0001433025,0.0001405337,0.0002162198,0.0009631158,0.00004121557,0.00004847485,0.00003898514,0.00003913014,0.000009767603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006627638,"about_ca_system_score_gemma":0.0004014212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001207112,"about_ca_topic_score_gemma":0.001793086,"domain_scores_codex":[0.9987459,0.0001074161,0.000296639,0.0003937897,0.0002373633,0.0002188486],"domain_scores_gemma":[0.9992222,0.0001891862,0.0001179963,0.0002432766,0.00008818709,0.0001392034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001855278,0.001162591,0.9723426,0.0009407107,0.0005701163,0.00005923234,0.0003686279,0.007344327,0.000926932,0.0001501147,0.00003744367,0.014242],"study_design_scores_gemma":[0.01183246,0.000310846,0.9780531,0.0002391665,0.0009439551,0.000001389746,0.0001200325,0.002650245,0.005004323,0.00001387861,0.0006958079,0.0001348002],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961625,0.001479323,0.0002613651,0.0002036956,0.00005989821,0.001334976,0.0001177303,0.0000317404,0.0003487853],"genre_scores_gemma":[0.9982562,0.0001127547,0.0003388595,0.0001452438,0.00003399655,0.0009950043,0.00004587635,0.00001732517,0.00005473226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0141072,"threshold_uncertainty_score":0.5730796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0681199910779398,"score_gpt":0.3507224088310248,"score_spread":0.282602417753085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}